Venetoclax for patients with chronic lymphocytic leukemia who progressed during or after idelalisib therapy
- Steven Coutre*
- , Michael Choi
- , Richard R. Furman
- , Herbert Eradat
- , Leonard Heffner
- , Jeffrey A. Jones
- , Brenda Chyla
- , Lang Zhou
- , Suresh Agarwal
- , Tina Waskiewicz
- , Maria Verdugo
- , Rod A. Humerickhouse
- , Jalaja Potluri
- , William G. Wierda
- , Matthew S. Davids
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
128
Scopus
citations